Christopher Nelson
Family Medicine · Gray Court, SCNPI 1558305029
Payments from drug & device makers
Across 67 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$166
- Pfizer$151
- Exact Sciences$110
- Novartis$107
- Boehringer Ingelheim$87
- AbbVie$68
- plus $470 from 17 others
What the payments were for
- Food & beverage$1,160100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $166 |
| Pfizer | 8 | $151 |
| Exact Sciences | 7 | $110 |
| Novartis | 6 | $107 |
| Boehringer Ingelheim | 5 | $87 |
| AbbVie | 4 | $68 |
| AstraZeneca | 4 | $67 |
| Sanofi Pasteur Inc. | 2 | $54 |
| Novo Nordisk | 3 | $48 |
| Amgen | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Edwards Lifesciences | 1 | $29 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Cranial Technologies, Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Insmed, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$1,160 in reported general payments places this provider in the 60th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 274 | $123,641 |
| JardianceEmpagliflozin | 140 | $88,055 |
| XareltoRivaroxaban | 110 | $59,503 |
| OzempicSemaglutide | 40 | $39,794 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 34 | $28,928 |
| LinzessLinaclotide | 38 | $28,503 |
| TrulicityDulaglutide | 29 | $28,030 |
| Breo ElliptaFluticasone/Vilanterol | 51 | $25,359 |
| MounjaroTirzepatide | 14 | $24,595 |
| MyrbetriqMirabegron | 27 | $21,951 |
| FarxigaDapagliflozin Propanediol | 62 | $20,318 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 42 | $18,427 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $16,881 |
| EntrestoSacubitril/Valsartan | 31 | $16,394 |
| JanuviaSitagliptin Phosphate | 17 | $15,940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $151 | $123,641274 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $87 | $98,128158 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Bevespi Aerosphere | $67 | $63,853136 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $18 | $52,62543 claims |
| Novo NordiskOzempic | $48 | $39,79440 claims |
| GSKBreo Ellipta, Anoro Ellipta, Shingrix | $166 | $36,26590 claims |
| AbbVieLinzess | $68 | $28,50338 claims |
| NovartisEntresto | $107 | $16,39431 claims |
| MerckJanuvia | $19 | $15,94017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Gray Court
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.